New mechanism discovered for aspirin’s cancer-fighting properties

LMU researchers have identified a signaling pathway by which aspirin can inhibit colorectal cancer.

Dual CRISPR-Cas3 is a promising tool to induce a gigantic genomic deletion and restore dystrophin protein

Researchers evaluated the use of a dual clustered regularly interspaced short palindromic repeats (CRISPR)-Cas3 system.

August 29, 2023

Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer

Combining retifanlimab (Zynyz) with standard-of-care chemotherapy significantly improved progression-free survival (PFS) in treatment-naïve patients with locally advanced or metastatic squamous cell carcinoma of the anal

September 16, 2024

Resilience secures funds to enhance production of essential medicine components

The funding will enable Aralez Bio to enhance cGMP production capabilities by leveraging an advanced technology. Credit: National Resilience/Business Wire. National Resilience’s subsidiary Resilience Government

October 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.